Found: 8
Select item for more details and to access through your institution.
Mifepristone mediates anti-proliferative effect on ovarian mesenchymal stem/stromal cells from female BRCA<sup>1-/2-</sup> carriers.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Antiprogestins reduce epigenetic field cancerization in breast tissue of young healthy women.
- Published in:
- Genome Medicine, 2022, v. 14, n. 1, p. 1, doi. 10.1186/s13073-022-01063-5
- By:
- Publication type:
- Article
Antiprogestins reduce epigenetic field cancerization in breast tissue of young healthy women.
- Published in:
- Genome Medicine, 2022, v. 14, n. 1, p. 1, doi. 10.1186/s13073-022-01063-5
- By:
- Publication type:
- Article
Correction: Antiprogestins reduce epigenetic field cancerization in breast tissue of young healthy women.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
Antiprogestins reduce epigenetic field cancerization in breast tissue of young healthy women.
- Published in:
- Genome Medicine, 2022, v. 14, n. 1, p. 1, doi. 10.1186/s13073-022-01063-5
- By:
- Publication type:
- Article
Characterization of Molecular Changes in Endometrium Associated With Chronic Use of Progesterone Receptor Modulators: Ulipristal Acetate Versus Mifepristone.
- Published in:
- Reproductive Sciences, 2018, v. 25, n. 3, p. 320, doi. 10.1177/1933719117746764
- By:
- Publication type:
- Article
Recent Advances in Understanding Endometrial Receptivity: Molecular Basis and Clinical Applications.
- Published in:
- American Journal of Reproductive Immunology, 2014, v. 72, n. 2, p. 148, doi. 10.1111/aji.12226
- By:
- Publication type:
- Article
Endometrial Receptivity and Human Embryo Implantation.
- Published in:
- American Journal of Reproductive Immunology, 2011, v. 66, p. 23, doi. 10.1111/j.1600-0897.2011.01048.x
- By:
- Publication type:
- Article